A legislative committee yesterday adopted a resolution demanding that Academia Sinica President Wong Chi-huey (翁啟惠) return to Taiwan from the US as soon as possible to clear up a controversy in connection with alleged insider trading of a pharmaceutical company’s shares.
If Wong cannot return to Taiwan immediately, he should submit a written report to the Legislative Yuan’s Education and Culture Committee within one week, the resolution said.
He is required to deliver an oral report to the committee within one week of his return, it added.
Photo: Chu Pei-hsiung, Taipei Times
Wong, who is in the US for academic activities, had earlier said that he would return to Taiwan to attend a hearing on the case scheduled for yesterday.
On Tuesday, he called President Ma Ying-jeou (馬英九) to express his intention to resign from his post as head of the nation’s highest academic institution, citing health reasons, and tendered his written resignation on Wednesday.
Ma rejected Wong’s resignation and instructed him to return to Taiwan as soon as possible to report to him and the legislature, according to Presidential Office spokesman Charles Chen (陳以信).
Photo: Chien Jung-fong, Taipei Times
Academia Sinica is under the direct administrative supervision of the Presidential Office.
The controversy flared up following Wong’s endorsement of a new cancer drug by publicly listed biotech company OBI Pharma Inc (台灣浩鼎), even though the company announced on Feb. 21 that the drug had failed second and third-round clinical trials, news that sent the company’s stock price plunging.
Wong is a biochemist considered to be an expert on the theory behind OBI Pharma’s cancer drug.
On March 3, Wong issued a statement through Academia Sinica that he did not hold any shares in Taiwan’s biotech companies.
However, Next Magazine reported on Wednesday last week that Wong’s daughter, Wong Yu-shioh (翁郁秀), obtained 3 million OBI Pharma shares in 2012 at the price of NT$31 per share before it was listed on the emerging stock market.
The company was listed on the over-the-counter market at NT$310 per share the following year.
The revelation fueled accusations against Wong Chi-huey of a conflict of interests and possible insider trading.
An initial investigation found that Wong Yu-shioh sold more than 10,000 of her OBI Pharma shares three months before the announcement of the cancer drug’s trial failure.
Wong Chi-huey yesterday penned a letter addressed to his Academia Sinica colleagues.
“My personal affairs have lately became the subject of public controversy, with an impact on our institution’s reputation that is profoundly disturbing to me. I am currently abroad and physically indisposed, and I am therefore unable to attend our March 30 report to the Legislative Yuan,” he said in the letter. “I had tendered my resignation to the president and will, upon concluding my affairs abroad, immediately return [to Taiwan] to make an explanation [about this affair].”
“I will continue in the future to dedicate my professional knowledge to science and biotechnological research in Taiwan,” he added.
KEEP AWAY: People should wear a mask in places where they cannot follow social distancing rules, the CECC said, adding that it would publish detailed guidelines today The Central Epidemic Command Center (CECC) yesterday announced 16 new cases of COVID-19, including two domestic cases, as it urged people to practice social distancing in public spaces by keeping a distance of at least 1m when outdoors and 1.5m indoors. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that seven of the new cases tested positive upon their arrival at the airport, four were under home quarantine, one was under home isolation and two were under self-health management, while the two domestic cases sought treatment on their own. The domestic cases are a man in his
Taiwan will negotiate with the WHO about its participation without Beijing’s help and intervention as more countries, including Australia and Japan, are partnering with Taiwan to curb the COVID-19 pandemic, the Ministry of Foreign Affairs said yesterday. US Secretary of State Mike Pompeo in a telephonic roundtable with reporters on Monday also supported Taiwan’s role in the WHO, saying the US Department of State would do its best to assist Taiwan’s “appropriate role” in the world’s highest health policy setting body, Voice of America reported. In a Japan Business Press report published on Sunday, Chinese Ambassador to Japan Kong Xuanyou (孔鉉佑) said
‘HEROIC’: A lack of personal protective equipment has led to high infection rates among health workers in places like Spain and Italy, a nurses’ association said More equipment is needed to protect the world’s nurses working on the front lines of the COVID-19 pandemic to save lives, the head of the International Council of Nurses (ICN) said. “They are heroic. I think there is no other way to describe what they are doing at this moment,” said Howard Catton, a British nurse who is the council’s CEO. Infection rates of 9 percent and 12 to 14 percent have been reported among health workers in Italy and Spain respectively, he said, adding that nurses have died in the two nations, as well as Iran and Indonesia. “We have no doubt
Japan’s ruling party yesterday proposed the nation’s biggest-ever stimulus package of ￥60 trillion (US$554 billion) as the COVID-19 pandemic locks the economy in a recession. The sum includes ￥20 trillion in fiscal measures with private initiatives and other elements likely making up the rest, the proposal by the Liberal Democratic Party showed. More than ￥10 trillion, or the equivalent of a 5 percentage point cut in the sales tax rate, would be handed out to the public in a combination of cash, subsidies and coupons, the plan showed. The proposal puts an initial figure on a stimulus package that Japanese Prime Minister Shinzo